Lucy Kilburn - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Lucy Kilburn

This paper was not found in any repository, but could be made available legally by the author.

2023 Maria Coakley

ORCID

, Guillermo Villacampa

ORCID

, Prithika Sritharan

ORCID

ORCID

, Kathryn Dunne

ORCID

, Lucy Kilburn

ORCID

, Katie Goddard

ORCID

, Christodoulos Pipinikas

ORCID

, Patricia Rojas

ORCID

, Warren Emmett

ORCID

ORCID

, Catherine Harper-Wynne

ORCID

, Tamas Hickish

ORCID

, Iain Macpherson

ORCID

, Alicia Okines

ORCID

and 9 other authors

Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Belinda Kingston

ORCID

ORCID

, Maria Teresa Herrera-Abreu

ORCID

ORCID

, Rosalind J. Cutts

ORCID

ORCID

, Laura Moretti

ORCID

, Lucy S. Kilburn

ORCID

, Hannah Johnson

ORCID

, Iain R. Macpherson

ORCID

, Alistair Ring

ORCID

, Judith M. Bliss

ORCID

ORCID

ORCID

, John A. Katzenellenbogen

ORCID

and 2 other authors

ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Alistair Ring

ORCID

, Lucy S. Kilburn

ORCID

ORCID

, Laura Moretti

ORCID

, Angelica Afshari-Mehr

ORCID

, Andrew M. Wardley

ORCID

ORCID

, Iain R. Macpherson

ORCID

, Ruth Riisnaes

ORCID

, Richard D. Baird

ORCID

ORCID

, Rebecca Roylance

ORCID

, Hannah Johnson

ORCID

ORCID

, Matthew C. Winter

ORCID

and 9 other authors

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

This paper was not found in any repository, but could be made available legally by the author.

Holly Tovey

ORCID

, Orsolya Sipos

ORCID

, Joel S. Parker

ORCID

, Katherine A. Hoadley

ORCID

ORCID

, Sarah Kernaghan

ORCID

, Lucy Kilburn

ORCID

, Roberto Salgado

ORCID

ORCID

, Richard D. Kennedy

ORCID

, Ioannis Roxanis

ORCID

, Patrycja Gazinska

ORCID

, Sarah E. Pinder

ORCID

ORCID

, Charles M. Perou

ORCID

and 4 other authors

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Mitch Dowsett, Lucy Kilburn

ORCID

, Mothaffar F. Rimawi, C. Kent Osborne, C. Kent Osborne, Katherine Pogue-Geile, Yuan Liu, Samuel A. Jacobs, Melanie Finnigan, Shannon Puhalla, Andrew Dodson

ORCID

, Vera Martins, Maggie Chon U. Cheang

ORCID

, Sophie Perry, Chris Holcombe and 5 other authors

Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2− breast cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

B. Kingston, R. Cutts, M. Beaney, G. Walsh-Crestani, S. Hrebien, L. Kilburn

ORCID

, S. Kernaghan, L. Moretti, K. Wilkinson, I. MacPherson, R. D. Baird, R. Roylance, J. S. Reis-Filho, M. Hubank, I. Faull and 5 other authors

99P Analysis of ctDNA in advanced breast cancer reveals polyclonal disease associated with adverse outcome

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Javier Pascual, Rosalind J. Cutts, Belinda Kingston, Sarah Hrebien, Lucy Kilburn

ORCID

, Sarah Kernaghan, Laura Moretti, Katie Wilkinson, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Michael Hubank, Giselle Walsh, Iris Faull and 6 other authors

Assessment of early ctDNA dynamics to predict efficacy of targeted therapies in metastatic breast cancer: Results from plasmaMATCH trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Eugene F. Schuster, Hui Xiao, Elena Lopez Knowles, Lucy Kilburn

ORCID

, Mothaffar Rimawi, David A. Wheeler, Katherine Pogue-Geile, Yuan Lui, Samuel A. Jacobs, Chet Cornman, Shannon Puhalla, Maggie Cheang, Judith Bliss, Stephen Johnston, Mitch Dowsett

Biomarkers of resistance to palbociclib in ER plus primary breast cancer in the PALLET trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Ian Smith, John Robertson, Lucy Kilburn

ORCID

, Maggie Wilcox, Abigail Evans, Chris Holcombe, Kieran Horgan, Cliona Kirwan, Elizabeth Mallon, Mark Sibbering, Anthony Skene, Raghavan Vidya, Maggie Cheang, Jane Banerji, James Morden and 4 other authors

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Nicholas C. Turner, Belinda Kingston, Lucy S. Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter

ORCID

, Hannah Bye and 13 other authors

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Upload

This paper is made freely available by the publisher.

Holly Tovey, Joel S. Parker, Katherine A. Hoadley, Richard D. Kennedy, Orsolya Sipos, Lucy Kilburn

ORCID

, Sarah Kernaghan, Patrycja Gazinska, Syed Haider, Sarah E. Pinder, Judith Bliss, Charles M. Perou, Anita Grigoriadis, Andrew Tutt, Maggie Chon U. Cheang

Evaluation of DNA repair biology signatures to predict specific carboplatin (C) versus docetaxel (D) benefit in advanced triple-negative breast cancer (aTNBC).

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Alistair Ring, Belinda Kingston, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter

ORCID

, Hannah Bye and 10 other authors

Results from plasmaMATCH: a multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Andrew M. Wardley, Lucy Kilburn

ORCID

, Sarah Kernaghan, Iain Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter, Belinda Kingston, Katie Wilkinson, Judith Bliss and 2 other authors

Results from plasmaMATCH trial treatment cohort B: A phase II trial of neratinib plus fulvestrant in ER positive breast cancer or neratinib alone in ER negative breast cancer in patients with a HER2 mutation identified via ctDNA screening (CRUK/15/010)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Nicholas Turner, Belinda Kingston, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain Macpherson, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter, Hannah Bye and 10 other authors

Results from the plasmaMATCH trial: A multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer (CRUK/15/010)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Richard D. Baird, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain Macpherson, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter, Belinda Kingston, Katie Wilkinson, Nicholas Turner and 2 other authors

Results from plasmaMATCH trial treatment cohort D: A phase II trial of capivasertib in patients with an AKT activation basket mutation identified via ctDNA testing or tumour sequencing (CRUK/15/010)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Belinda Kingston, Hannah Bye, Michael Hubank, Giselle Walsh, Claire Swift, Matthew Beaney, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain Macpherson, Richard D. Baird, Rebecca Roylance, Katie Wilkinson, Isaac Garcia-Murillas, Judith Bliss and 2 other authors

The genomic landscape of breast cancer based on ctDNA analysis: Data from the plasmaMATCH trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Rebecca Roylance, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Iain Macpherson, Richard D. Baird, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter, Belinda Kingston, Katie Wilkinson, Alistair Ring and 2 other authors

Results from plasmaMATCH trial treatment cohort C: A phase II trial of capivasertib plus fulvestrant in ER positive breast cancer patients with an AKT1 mutation identified via ctDNA screening (CRUK/15/010)

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Iain Macpherson, Lucy Kilburn

ORCID

, Sarah Kernaghan, Andrew M. Wardley, Richard D. Baird, Rebecca Roylance, Peter Stephens, Olga Oikonomidou, Jeremy P. Braybrooke, Mark Tuthill, Jacinta Abraham, Matthew C. Winter, Belinda Kingston, Katie Wilkinson, Alistair Ring and 2 other authors

Results from plasmaMATCH trial treatment cohort A: A phase II trial of extended-dose fulvestrant in patients with an ESR1 mutation identified via ctDNA screening (CRUK/15/010)

Upload

This paper is made freely available by the publisher.

Susana Banerjee

ORCID

, Holly Tovey, Rebecca Bowen, Elizabeth Folkerd, Lucy Kilburn

ORCID

, Jennifer McLachlan, Marcia Hall, Nina Tunariu, Ayoma Attygalle, Joao Paulo Da Silveira Nogueira Lima, Sophie Perry, Peter Chatfield, Margaret Hills, Stan Kaye, Gert Attard and 2 other authors

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2019 Sarah Kernaghan, Laura Moretti, Lucy Kilburn

ORCID

, Katie Wilkinson, Claire Snowdon, James Morden, Iain Macpherson, Andrew Wardley, Rebecca Roylance, Richard Baird, Alistair Ring, Nicholas Turner, Judith Bliss

The UK plasma based Molecular profiling of Advanced breast cancer to inform Therapeutic CHoices (plasmaMATCH) Trial: A multiple parallel-cohort, phase IIa platform trial aiming to provide proof of principle efficacy for designated targeted therapies in patient subgroups identified through ctDNA screening (CRUK/15/010)

Upload

Missing publications? Search for publications with a matching author name.